Kisspeptin

KISSPEPTIN 10MG

Reproductive • Hormonal • Sexual Wellness Support
Kisspeptin is a naturally occurring signalling peptide that plays a central role in the hypothalamic–pituitary–gonadal (HPG) axis. It stimulates the release of GnRH, which subsequently regulates LH and FSH, two key hormones involved in reproductive and sexual function.

KEY POTENTIAL BENEFITS

Supports natural GnRH, LH & FSH signalling
Supports healthy reproductive hormone function
Investigated for fertility and reproductive health

May support libido and sexual wellbeing
Plays a role in normal ovarian and menstrual-cycle signalling
Emerging research interest for women experiencing hormonal changes around perimenopause

May support sexual desire in some women
Human research in premenopausal women with hypoactive sexual desire disorder found that kisspeptin influenced sexual and attraction-related brain processing and increased LH/FSH signalling. However, this does not establish kisspeptin as a treatment for perimenopause.

PERIMENOPAUSE & WOMEN’S HEALTH

During perimenopause, reproductive hormone signalling becomes increasingly variable. Because kisspeptin is an upstream regulator of the reproductive hormonal axis, it is of research interest in female hormonal and sexual health.

It should not be described as a proven treatment for hot flushes, irregular periods, low estrogen, or other perimenopausal symptoms.

Current clinical evidence is much stronger for its role in reproductive signalling than for treating perimenopause itself.

POTENTIAL SIDE EFFECTS

Available human studies have generally found kisspeptin to be well tolerated, although research remains limited. Potential effects may include headache, flushing, nausea, light-headedness or injection-site irritation.

IMPORTANT

No universally established self-use dosing protocol exists. Research doses vary considerably depending on the form of kisspeptin, route of administration and research objective.
Storage: 2–8°C after reconstitution

Format: Lyophilised powder
Strength: 10mg

For research and educational purposes. Kisspeptin is not an established treatment for perimenopause or a substitute for clinically indicated menopausal hormone therapy.